[1] Beger RD, Bhattacharyya S, Yang X, et al. Translational biomarkers of acetaminophen-induced acute liver injury. Arch Toxicol, 2015,89: 1497-1522.
[2] Wood PR,Caplan L. Drug-Induced Gastrointestinal and Hepatic Disease Associated with Biologics and Nonbiologic Disease-Modifying Antirheumatic Drugs. Rheum Dis Clin North Am, 2018, 44: 29-43.
[3] McGill MR, Sharpe MR, Williams CD, et al. The mechanism underlying acetaminophen-induced hepatotoxicity in humans and mice involves mitochondrial damage and nuclear DNA fragmentation. J Clin Invest, 2012,122:1574-1583.
[4] Danan G,Teschke R. RUCAM in Drug and Herb Induced Liver Injury: The Update. Int J Mol Sci, 2015, 17. pii: E14.
[5] 高旭东. 药物性肝损伤临床研究及诊断标准探讨. 北京:北京中医药大学,2009.
[6] 李军,白娟,窦科峰,等. β细胞素下调对肝癌细胞增殖能力的影响及其机制探讨. 陕西医学杂志,2016, 45: 643-645, 655.
[7] Li C, Ming Y, Hong W, et al. Comparison of hepatic transcriptome profiling between acute liver injury and acute liver failure induced by acetaminophen in mice. Toxicol Lett, 2018, 283: 69-76.
[8] 周琼. 小鼠急性肝损伤模型的建立及GSTA1分析. 哈尔滨:东北农业大学,2012. |
